A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

  • Sang-In Park, Howard Lee, Jaeseong Oh, Kyoung Soo Lim, In-Jin Jang, Kyung-Sang Yu, Jong Hyuk Jung, Jeong-Ae Kim
  • Drug Design Development and Therapy, February 2015, Taylor & Francis
  • DOI: 10.2147/dddt.s75980

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Howard Lee, Jeong-Ae Kim, and Jaeseong Oh